Search - tctmd.com

Displaying 1 - 20 of 209

Sort: Relevancy | Date

Presentation CTO 2026

Impella-Assisted PCI Using Dual vs Single Access: Increased Bleeding Risk With Dual Access

Presenter: Ivan Aivasovsky

February 13, 2026

Presentation TCT 2025

TCT 965: Can Machine Learning Aid the Evaluation of the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After PCI?

Presenter: Hao-Yu Wang

October 28, 2025

Presentation TCT 2025

TCT 744: Risk of Recurrent Gastrointestinal Bleeding in Patients with Atrial Fibrillation Treated With or Without Left Atrial Appendage Occlusion: A Propensity-Matched Analysis

Presenter: Adham Ramadan

October 28, 2025

Presentation TCT 2025

TCT 62: Long-Term Outcomes of Patients at Both High Ischemic and Bleeding Risk (Bi-Risk) on Clopidogrel-Based Dual Antiplatelet Therapy, Insights from the UF-GENOTYPE Registry.

Presenter: Claudio Laudani

October 28, 2025

Presentation TCT 2025

TCT 742: Risks of Major Bleeding and Hospitalization for Falls After Left Atrial Appendage Occlusion in Patients with Atrial Fibrillation and History of Falls: A Propensity-Matched Analysis

Presenter: Mohamed Doma

October 28, 2025

Presentation TCT 2025

TCT 1015: External Validation of the xDAPT Machine Learning Model for Ischemic and Bleeding Risk After Percutaneous Coronary Intervention

Presenter: Davide Cao

October 28, 2025

Presentation TCT 2025

Reperfuse First and Avoid Bleeding

Presenter: Vijay Kunadian

October 27, 2025

Presentation TCT 2025

TCT 1010: Long‑Term Prognostic Significance of High Ischemic versus High Bleeding Risk Phenotypes After Percutaneous Coronary Intervention: HOST-EXAM Extended Study Post Hoc Analysis

Presenter: Jin-Eun Song

October 27, 2025

Presentation TCT 2025

TCT 999: One- versus three-month DAPT in patients at high or very high bleeding risk undergoing PCI: Results from the XIENCE Short DAPT Program

Presenter: Davide Cao

October 27, 2025

Presentation TCT 2025

TCT 996: One-versus three-month DAPT in High Bleeding Risk Patients With or Without Baseline Anemia Undergoing PCI

Presenter: Francesca Maria Di Muro

October 27, 2025

Presentation TCT 2025

TCT 1824: Going Beyond Metal: The Treatment of a Highly Calcified Long LAD Lesion With Rotatripsy and Sirolimus-Coated Balloon in a Patient With Low Ejection Fraction and High-Bleeding Risk

Presenter: Tuomas T. Rissanen

October 26, 2025

Presentation TCT 2025

TCT 1822: Treating a Severely Calcified Left Main With Nodular Calcium: Lithotripsy and DCB-Only Strategy in a High Bleeding Risk Case

Presenter: Edgar Stroppa Lamas

October 26, 2025

Presentation TCT 2025

TCT 143: Safety and Efficacy of Calcium Modification Techniques in Patients With and Without High Bleeding Risk Undergoing PCI

Presenter: Joseph Cotton

October 26, 2025

Presentation TCT 2025

TCT 52: Differential Prognostic Impact of Potent P2Y12 inhibitors in Patients with Acute Myocardial Infarction According to Bleeding Risk

Presenter: Seung Hun Lee

October 26, 2025

Presentation TCT 2025

Antiplatelet Therapy in High Bleeding Risk Patients Following Complex PCI: A HOST-BR Trial Sub-Study

Presenter: Hyo-Soo Kim

October 25, 2025

Presentation TCT 2025

Aspirin Monotherapy After 1-Month DAPT in High Bleeding Risk Patients Undergoing PCI: The TARGET SAFE Randomized Trial

Presenter: Miaohan Qiu

October 25, 2025

Presentation NY Valves 2025

My Patient Has Severe Primary MR, Symptomatic AF, and is at High Risk for Stroke and Bleeding: How Do I Time M-TEER and LAAO/Ablation?

Presenter: Matthew J. Price

June 26, 2025

Presentation ACC 2025

Dual Antiplatelet Therapy After PCI According To Bleeding Risk: HOST-BR RCT

Presenter: Hyo-Soo Kim

March 29, 2025

Presentation TCT 2024

TCT 1248: Drug-Coated Balloon Alone Strategy to Avoid Multiple Stenting in a Patient With High Bleeding Risk

Presenter: Marco Luciano Rossi

October 30, 2024

Presentation TCT 2024

TCT 959: Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Marisa Avvedimento

October 30, 2024

Advertisement

Impella-Assisted PCI Using Dual vs Single Access: Increased Bleeding Risk With Dual Access

TCT 965: Can Machine Learning Aid the Evaluation of the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After PCI?

TCT 744: Risk of Recurrent Gastrointestinal Bleeding in Patients with Atrial Fibrillation Treated With or Without Left Atrial Appendage Occlusion: A Propensity-Matched Analysis

TCT 62: Long-Term Outcomes of Patients at Both High Ischemic and Bleeding Risk (Bi-Risk) on Clopidogrel-Based Dual Antiplatelet Therapy, Insights from the UF-GENOTYPE Registry.

TCT 742: Risks of Major Bleeding and Hospitalization for Falls After Left Atrial Appendage Occlusion in Patients with Atrial Fibrillation and History of Falls: A Propensity-Matched Analysis

TCT 1015: External Validation of the xDAPT Machine Learning Model for Ischemic and Bleeding Risk After Percutaneous Coronary Intervention

Reperfuse First and Avoid Bleeding

TCT 1010: Long‑Term Prognostic Significance of High Ischemic versus High Bleeding Risk Phenotypes After Percutaneous Coronary Intervention: HOST-EXAM Extended Study Post Hoc Analysis

TCT 999: One- versus three-month DAPT in patients at high or very high bleeding risk undergoing PCI: Results from the XIENCE Short DAPT Program

TCT 996: One-versus three-month DAPT in High Bleeding Risk Patients With or Without Baseline Anemia Undergoing PCI

TCT 1824: Going Beyond Metal: The Treatment of a Highly Calcified Long LAD Lesion With Rotatripsy and Sirolimus-Coated Balloon in a Patient With Low Ejection Fraction and High-Bleeding Risk

TCT 1822: Treating a Severely Calcified Left Main With Nodular Calcium: Lithotripsy and DCB-Only Strategy in a High Bleeding Risk Case

TCT 143: Safety and Efficacy of Calcium Modification Techniques in Patients With and Without High Bleeding Risk Undergoing PCI

TCT 52: Differential Prognostic Impact of Potent P2Y12 inhibitors in Patients with Acute Myocardial Infarction According to Bleeding Risk

Antiplatelet Therapy in High Bleeding Risk Patients Following Complex PCI: A HOST-BR Trial Sub-Study

Aspirin Monotherapy After 1-Month DAPT in High Bleeding Risk Patients Undergoing PCI: The TARGET SAFE Randomized Trial

My Patient Has Severe Primary MR, Symptomatic AF, and is at High Risk for Stroke and Bleeding: How Do I Time M-TEER and LAAO/Ablation?

Dual Antiplatelet Therapy After PCI According To Bleeding Risk: HOST-BR RCT

TCT 1248: Drug-Coated Balloon Alone Strategy to Avoid Multiple Stenting in a Patient With High Bleeding Risk

TCT 959: Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing Transcatheter Aortic Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content